Showing results (321-330 of 329) with videos related to
Sort By:
Pageof 33
You have reached the last page of results.This site can display upto 329 results.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 23, 2022
Fibrotic immune microenvironment remodeling mediates superior anti-tumor efficacy of a nano-PD-L1 trap in hepatocellular carcinomaXiaoyu Liu, Jingying Zhou, Haoran Wu, et al.Plos One|October 14, 2014
The cytochrome P450 epoxygenase pathway regulates the hepatic inflammatory response in fatty liver diseaseRobert N Schuck, Weibin Zha, Matthew L Edin, et al.Science Advances|September 13, 2021
The anti-fibrotic drug pirfenidone inhibits liver fibrosis by targeting the small oxidoreductase glutaredoxin-1Yue Xi, Yanping Li, Pengfei Xu, et al.JCI Insight|November 16, 2018
A nanoparticle-incorporated STING activator enhances antitumor immunity in PD-L1-insensitive models of triple-negative breast cancerNing Cheng, Rebekah Watkins-Schulz, Robert D Junkins, et al.Gut|September 24, 2017
Hepatoma-intrinsic CCRK inhibition diminishes myeloid-derived suppressor cell immunosuppression and enhances immune-checkpoint blockade efficacyJingying Zhou, Man Liu, Hanyong Sun, et al.Cancer Research|September 26, 2020
A Circle RNA Regulatory Axis Promotes Lung Squamous Metastasis via CDR1-Mediated Regulation of Golgi TraffickingEmily B Harrison, Alessandro Porrello, Brittany M Bowman, et al.Nature Communications|December 8, 2018
An inflammatory-CCRK circuitry drives mTORC1-dependent metabolic and immunosuppressive reprogramming in obesity-associated hepatocellular carcinomaHanyong Sun, Weiqin Yang, Yuan Tian, et al.Nature Nanotechnology|July 11, 2019
Publisher Correction: On the issue of transparency and reproducibility in nanomedicineHon S Leong, Kimberly S Butler, C Jeffrey Brinker, et al.Nature Nanotechnology|July 31, 2019
Publisher Correction: On the issue of transparency and reproducibility in nanomedicineHon S Leong, Kimberly S Butler, C Jeffrey Brinker, et al.Pageof 33